Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non small-cell lung cancer

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 5, 1997, Pages 415-418

  Miller, Vincent A ^a   Rigas, James R ^a   Tong, William P ^a   Reid, Janice R ^a   Pisters, Katherine M W ^a   Grant, Stefan C ^a   Heelan, Robert T ^a   Kris, Mark G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CQS; HTCFA; NSCLC; Phase II trial

Indexed keywords

5 CHLOROSULFAQUINOXALINE;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; MORTALITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; QUINOXALINES; SULFANILAMIDES; TREATMENT FAILURE; TUMOR STEM CELL ASSAY;

EID: 0030847034     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050679     Document Type: Article

References (12)

1. Abbott L (1991) Abbottbase pharmacokinetic systems (version 1.00). Abbott Park
2. Branda RF, McCormack JJ, Perlmutter CA (1988) Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells. Biochem Pharmacol 37: 4557-4564
3. Eagan RT, Fleming TR, Schoonover V (1979) Evaluation of response criteria in advanced lung cancer. Cancer 44: 1125-1128
4. Jett JR, Su JQ, Krook JE, et al (1994) Measurable or assessable disease in lung cancer trials: does it matter? J Clin Oncol 12: 2677-2681
5. Johnson BE, Parker R, Tsai CM, et al (1993) Phase I trial of dihydrolenperone in lung cancer patients: a novel compound with in vitro activity against lung cancer. Invest New Drugs 11: 29-37
6. Kris MG, Gralla RJ, Kalman LA, et al (1985) Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small-cell lung cancer, with an analysis of methods of response assessment. Cancer Treat Rep 69: 387-395
7. Mountain CF (1986) A new international staging system for lung cancer. Chest 89: 225-233
8. Phillips RM, Bibby MC, Double JA (1990) A critical appraisal of the predictive value of in vitro chemosensitivity assays. J Natl Cancer Inst 82: 1457-1468
9. Rigas JR, Tong WP, Kris MG, et al (1992) Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide. Cancer Res 52: 6619-6623
10. Rigas JR, Francis PA, Miller VA, et al (1995) Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule. Cancer Chemother Pharmacol 35: 483-488
11. Shoemaker R (1986) New approaches to antitumor drug screening: the human tumor colony forming assay. Cancer Treat Rep 70: 9-12
12. Tong WP, Hartshorn J, Mathews LA (1987) Chloroquinoxaline sulfonamide, investigational drug brochure. National Cancer Institute, Division of Cancer Treatment